Androgenetic alopecia vs. telogen effluvium is a comparison between progressive hair thinning and a disturbance of the hair growth cycle that causes excessive shedding. Both can make the scalp more visible, but they do not necessarily require the same response. Before considering a hair transplant, the important question is whether the follicles are producing increasingly fine hairs, shedding more hairs than usual, or experiencing both processes together.
Quick Answer
Androgenetic Alopecia vs. Telogen Effluvium: What Changes Beneath the Scalp?
In androgenetic alopecia, susceptible follicles gradually undergo miniaturisation. Over successive growth cycles, they produce hairs that are finer, shorter and less effective at covering the scalp. Someone may notice that their hairstyle no longer holds its shape or that their scalp shows through under bright light, even without a dramatic increase in hair on the brush.
In men, this often appears as recession at the temples and thinning around the crown. In women, a widening part and reduced density over the top of the scalp are common. These patterns offer clues, although appearance alone cannot confirm the diagnosis.
Telogen effluvium follows a different course. More follicles than usual move into the resting phase, and the affected hairs are subsequently shed. An illness, childbirth, surgery, substantial weight loss or another significant physical or emotional stressor may precede the change. The shedding often becomes noticeable two to four months later, which can make the connection difficult to recognise.
The loss usually affects the scalp more widely. Importantly, shedding a hair shaft does not mean that the follicle beneath the skin has been destroyed. In many cases, growth can recover as the disturbance resolves.

Can You Have Both Conditions at the Same Time?
Yes. A person can have underlying androgenetic alopecia and develop telogen effluvium as well. This is one reason the androgenetic alopecia vs. telogen effluvium distinction cannot be settled simply by counting shed hairs.
Consider someone whose hair has slowly lost volume over several years, followed by a sudden period of heavy shedding after an illness. The recent shedding may be temporary, while the earlier thinning reflects a continuing process. Even when the shedding improves, the underlying pattern loss may remain.
The British Association of Dermatologists’ guidance on telogen effluvium explains that the two conditions can occur together. It also notes that telogen effluvium lasting more than six months is considered chronic. “Temporary” therefore does not mean that every case resolves quickly or follows an identical timetable.
An assessment should examine the history, distribution of thinning and condition of the scalp. Magnified examination can help evaluate hair thickness and signs of miniaturisation. Where the history or findings suggest it, a clinician may investigate factors such as iron deficiency or thyroid disease. Testing should answer a clinical question rather than become a standard package for everyone.
What Does the Diagnosis Mean for a Hair Transplant?
When telogen effluvium is the main issue, transplanting additional follicles does not address the reason the existing hairs are shedding. The appropriate starting point is to investigate the cause and allow recovery to be assessed. Operating before that picture becomes clear can commit a limited donor reserve to an area whose appearance may still change.
Androgenetic alopecia requires a different discussion. Medical management may help preserve existing hair, and transplantation may be appropriate for a suitable candidate. However, surgery redistributes follicles; it does not stop the underlying hair-loss process. The design must account for future thinning and the capacity of the donor area.
A visible area of thinning tells us where the problem appears. It does not, by itself, tell us what should be done.
In The Hair Transplant Doctrine, I place this decision before technique selection and graft numbers. My earlier article on hair loss diagnosis before a hair transplant explores that starting point. Understanding the cause gives us a basis for deciding whether to treat, monitor or consider surgery—and for protecting the options a person may need later.
Frequently Asked Questions
What are the main clinical signs of androgenetic alopecia?
How soon after a stressful event does telogen effluvium shedding begin?
Can a person experience telogen effluvium and androgenetic alopecia simultaneously?
Why is telogen effluvium lasting over six months considered unique?
Why is a hair transplant unsuitable as a primary treatment for telogen effluvium?
